PAR3 (1-6) (human)
Need Assistance?
  • US & Canada:
    +1-844-BOC(262)-0123
  • UK: +44-20-3286-1088

PAR3 (1-6) (human)

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

PAR3 (1-6) is a synthetic hexapeptide agonist of proteinase-activated receptor 1 (PAR1). PAR1 is a high-affinity thrombin receptor expressed in epithelium, neurons, astrocytes, immune cells, and cancer-associated fibroblasts.

Category
Peptide Inhibitors
Catalog number
BAT-015084
CAS number
320347-28-2
Molecular Formula
C29H45N9O8
Molecular Weight
647.72
PAR3 (1-6) (human)
IUPAC Name
(2S)-1-[(2S)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-amino-3-hydroxybutanoyl]amino]-3-phenylpropanoyl]amino]-5-(diaminomethylideneamino)pentanoyl]amino]acetyl]amino]propanoyl]pyrrolidine-2-carboxylic acid
Synonyms
Thrombin Receptor-Like 2 (1-6) (human); L-threonyl-L-phenylalanyl-L-arginyl-glycyl-L-alanyl-L-proline; H-TFRGAP-OH; L-Proline, L-threonyl-L-phenylalanyl-N5-(diaminomethylene)-L-ornithylglycyl-L-alanyl-; L-Threonyl-L-phenylalanyl-N5-(diaminomethylene)-L-ornithylglycyl-L-alanyl-L-proline
Appearance
Crystalline Solid
Purity
≥98%
Density
1.46±0.1 g/cm3
Sequence
H-Thr-Phe-Arg-Gly-Ala-Pro-OH
Storage
Store at -20°C
Solubility
Soluble in DMF, DMSO, Ethanol, PBS (pH 7.2)
InChI
InChI=1S/C29H45N9O8/c1-16(27(44)38-13-7-11-21(38)28(45)46)35-22(40)15-34-24(41)19(10-6-12-33-29(31)32)36-25(42)20(14-18-8-4-3-5-9-18)37-26(43)23(30)17(2)39/h3-5,8-9,16-17,19-21,23,39H,6-7,10-15,30H2,1-2H3,(H,34,41)(H,35,40)(H,36,42)(H,37,43)(H,45,46)(H4,31,32,33)/t16-,17+,19-,20-,21-,23-/m0/s1
InChI Key
LGNVPMUJJJLQHG-WZZXNIEWSA-N
Canonical SMILES
CC(C(C(=O)NC(CC1=CC=CC=C1)C(=O)NC(CCCN=C(N)N)C(=O)NCC(=O)NC(C)C(=O)N2CCCC2C(=O)O)N)O
1. PAR-3 is a low-affinity substrate, high affinity effector of thrombin
Whyte G Owen Biochem Biophys Res Commun . 2003 May 23;305(1):166-8. doi: 10.1016/s0006-291x(03)00732-0.
A polypeptide corresponding to the extracellular domain of protease-activated receptor 3 (PAR-3) is hydrolyzed by thrombin slowly because of high K(M) (>100 microM). However, thrombin is found to bind two PAR-3, one without catalyzing hydrolysis or blocking the active site, while the other is hydrolyzed. In a solvent lacking Na(+), hydrolysis of a nitroanilide substrate is enhanced 1.6-fold by addition of PAR-3 polypeptide, with half-saturation at 2.5 microM. In contrast, the fibrinogen clotting activity of thrombin is inhibited completely by PAR-3, with a K(I) of 3 microM. None of the activities of thrombin are affected by addition of 50 microM PAR-4 polypeptide. Thus, PAR-3 in low concentrations binds thrombin in a configuration that blocks the anion-binding exosite but not the catalytic site, while hydrolysis of PAR-3, PAR-4, and other substrates that do not interact with exosite I persists. The allosteric effect of PAR-3 is characteristic of that of Na(+).
Online Inquiry
0
Inquiry Basket

No data available, please add!

Delete selectedGo to checkout

We use cookies to understand how you use our site and to improve the overall user experience. This includes personalizing content and advertising. Read our Privacy Policy

x